Ferritin Quantitative Test

SARS-CoV-2 Antigen Rapid Qualitative Test Type A

Product Detail

Application


The SARS-CoV-2 Antigen Rapid Qualitative Test is intended for the qualitative detection of SARS-CoV-2 nucleocapsid antigens in human nasal swabs samples from individuals who are suspected of COVID-19. The test is intended as an aid in diagnosis of symptomatic individuals within the first 7 days of symptom onset.



Product Features


Fast Result
Easy-to-use
High specificity and sensitivity
Room temperature storage


Leave A Message

Please provide us with the information below, and we'll contact you as soon as possible.

Related Products
FIA Analyzer
FLI-100 FIA Analyzer
The ALL NEW FLI-100 Analyser represents an elevated standard at Biotime, in pursuing simplicity, quality assurance, and data security for healthcare organizations. Designed for quantitative in vitro assay determinations, the Biotime FLI-100 analyser was purposefully built to support immunoassay analysis for a broad range of applications – from biomarker work to infectious disease testing. The analyser’s immunofluorescence technology yields high sensitivity, reliable, and reproducible results for convenient point-of-care diagnostic testing on one device with a small footprint.
The ADV Antigen Qualitative Rapid Test
The ADV Antigen Rapid Test
The ADV Antigen Rapid Test is a rapid lateral flow immunoassay for the qualitative detection of adenovirus antigen (ADV) directly from nasal/throat/nasopharyngeal swabs. It is intended to be used by professionals as a screening test and to provide preliminary test results to help diagnose acute Adenovirus infection. It provides only an initial screening test result. For professional in vitro diagnostic use only.
SAA Rapid Quantitative Test (Chemiluminescence Immunoassay)
SAA Rapid Quantitative Test (Chemiluminescence Immunoassay)
SAA Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Serum amyloid A (SAA) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of inflammation diseases.
Biotime Myo Rapid Quantitative Test
Myo Rapid Quantitative Test
Myo is the earliest marker after AMI, and it is a sensitive and accurate indicator to judge whether there is reperfusion in thrombolytic therapy. Biotime Myo test kit is mainly used to detect Myo quantity in human serum and plasma samples.
Biotime 25(OH)D Rapid Quantitative Test
25(OH)-D Rapid Quantitative Test
25(OH)-D is a prehormone that is produced in the liver by hydroxylation of vitamin D3 (cholecalciferol) by the enzyme cholecalciferol 25-hydroxylase. Physicians worldwide measure this metabolite to determine a patient's vitamin D status.
biotime CEA Rapid Quantitative Test
CEA Rapid Quantitative Test
Carcinoembryonic antigen (CEA) is a protein normally found in very low levels in the blood of adults. The CEA blood level may be increased in certain types of cancer and non-cancerous (benign) conditions. A CEA test is most commonly used for colorectal cancer.
Myo Rapid Quantitative Test (Chemiluminescence Immunoassay)
Myo Rapid Quantitative Test (Chemiluminescence Immunoassay)
Myo Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the myoglobin (Myo) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood, mainly used for auxiliary diagnosis of cardiac diseases.
Leave A Message

Leave A Message

    Please provide us with the information below, and we'll contact you as soon as possible.

Home

products

about

contact